MiMedx Group and Sanara MedTech announced they have entered into a definitive merger agreement. MIMEDX will acquire all outstanding shares of Sanara in a cash and stock transaction valued at $35 per ...
MiMedx Group faces a sharp downgrade from Buy to Hold as 2026 revenue guidance drops to $260–$290 million from $340–$360 million. Q1 2026 saw a 33% revenue decline, with wound care sales down 60% and ...
MARIETTA, Ga., April 02, 2026 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced its participation in two leading wound care conferences: the Symposium ...
MiMedx Group, Inc. announced the commercial launch of AMNIOFIX Thyroid Shields, a product line extension of the Company?s AMNIOFIX dehydrated human amnion/chorion membrane (DHACM) allografts. AMNIOFIX ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
MARIETTA, Ga. (AP) — MARIETTA, Ga. (AP) — MiMedx Group Inc. (MDXG) on Wednesday reported earnings of $15.2 million in its fourth quarter. On a per-share basis, the Marietta, Georgia-based company said ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results